BioNTech SE Total Non-Operating Income/Expense 2019-2025 | BNTX
BioNTech SE total non-operating income/expense for the twelve months ending March 31, 2025 was $0.592B, a 11.62% decline year-over-year.
- BioNTech SE annual total non-operating income/expense for 2024 was $0.689B, a 28.4% increase from 2023.
- BioNTech SE annual total non-operating income/expense for 2023 was $0.536B, a 63.52% increase from 2022.
- BioNTech SE annual total non-operating income/expense for 2022 was $0.328B, a 216.81% decline from 2021.